LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
-4.61%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.39B
AUM Growth
-$1.8B
(-43%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-61.99%
Top 10 Holdings %
Top 10 Hldgs %
56.42%
Holding
596
New
187
Increased
52
Reduced
54
Closed
244
Top Buys
| 1 |
Warner Bros
WBD
|
$213M |
| 2 |
Lowe's Companies
LOW
|
$62.8M |
| 3 |
Morgan Stanley
MS
|
$47M |
| 4 |
Citigroup
C
|
$46M |
| 5 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
$43M |
Top Sells
| 1 |
DISCA
Discovery, Inc. Series A Common Stock
DISCA
|
$338M |
| 2 |
International Flavors & Fragrances
IFF
|
$284M |
| 3 |
Alibaba
BABA
|
$167M |
| 4 |
T-Mobile US
TMUS
|
$166M |
| 5 |
Micron Technology
MU
|
$149M |
Sector Composition
| 1 | Healthcare | 31.34% |
| 2 | Communication Services | 18.76% |
| 3 | Consumer Discretionary | 15.12% |
| 4 | Utilities | 9.34% |
| 5 | Financials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Palo Alto Networks
PANW
$129B
| $2.45M | 0.04% |
29,802
+4,200
| +16% | +$346K |
|
102
Atossa Therapeutics
ATOS
$99.6M
| $2.43M | 0.04% |
+2,225,800
| New | +$2.43M |
|
103
Boston Scientific
BSX
$160B
| $2.41M | 0.04% |
64,781
+56,416
| +674% | +$2.1M |
|
104
Expedia Group
EXPE
$26.4B
| $2.35M | 0.04% |
+24,799
| New | +$2.35M |
|
|
IMA
105
ImageneBio, Inc. Common Stock
IMA
$104M
| $2.34M | 0.04% |
+44,083
| New | +$2.34M |
|
106
AstraZeneca
AZN
$254B
| $2.33M | 0.04% |
+35,225
| New | +$2.33M |
|
107
CytomX Therapeutics
CTMX
$336M
| $2.33M | 0.04% |
+1,270,900
| New | +$2.33M |
|
108
MetLife
MET
$54.3B
| $2.31M | 0.04% |
+36,842
| New | +$2.31M |
|
109
Healthcare Realty
HR
$6.15B
| $2.3M | 0.04% |
+84,459
| New | +$2.3M |
|
110
Amgen
AMGN
$151B
| $2.24M | 0.03% |
+9,221
| New | +$2.24M |
|
111
Werewolf Therapeutics
HOWL
$61.3M
| $2.19M | 0.03% |
+535,160
| New | +$2.19M |
|
112
IHS Holding
IHS
$2.4B
| $2.17M | 0.03% |
208,247
-73,159
| -26% | -$764K |
|
|
AKUS
113
DELISTED
Akouos, Inc. Common Stock
AKUS
| $2.14M | 0.03% |
+456,000
| New | +$2.14M |
|
114
Shattuck Labs
STTK
$58.4M
| $2.05M | 0.03% |
+506,000
| New | +$2.05M |
|
|
CMPS
115
Compass Pathways
CMPS
$473M
| $2.05M | 0.03% |
189,407
| – | – |
|
116
Olema Pharmaceuticals
OLMA
$412M
| $2.02M | 0.03% |
+495,300
| New | +$2.02M |
|
117
Mastercard
MA
$537B
| $2M | 0.03% |
6,328
-20,675
| -77% | -$6.52M |
|
118
Tenet Healthcare
THC
$16.9B
| $1.97M | 0.03% |
+37,428
| New | +$1.97M |
|
119
Ovintiv
OVV
$10.8B
| $1.77M | 0.03% |
+40,037
| New | +$1.77M |
|
|
RAIN
120
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $1.74M | 0.03% |
+313,200
| New | +$1.74M |
|
121
Coherent
COHR
$14.5B
| $1.74M | 0.03% |
+34,126
| New | +$1.74M |
|
122
Las Vegas Sands
LVS
$37.7B
| $1.73M | 0.03% |
51,591
-1,209,572
| -96% | -$40.6M |
|
123
4D Molecular Therapeutics
FDMT
$286M
| $1.71M | 0.03% |
245,123
| – | – |
|
124
Advanced Micro Devices
AMD
$260B
| $1.69M | 0.03% |
22,150
-51,900
| -70% | -$3.97M |
|
125
Analog Devices
ADI
$120B
| $1.69M | 0.03% |
11,552
-557,848
| -98% | -$81.5M |
|